Cancer Research and Treatment10.4143/crt.2022.14342023552684-692Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Seok Jin Kim, Young Rok Do, Gyeong-Won Lee, Jae-Yong Kwak, Yong Park, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Kwai Han Yoo, Won Sik Lee, Byeong Bae Park, Jae Cheol Jo, Hyeon-Seok Eom, Hyo Jung Kim, Seong Hyun Jeong, Young-Woong Won, Byeong Seok Sohn, Ji-Hyun Kwon, Cheolwon Suh, Won Seog Kim,,
Cancer Treatment Reviews10.1016/j.ctrv.2012.03.011201339151-59The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: A review of the literature and new perspectivesJean Yared, Amy Kimball,
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2019.09.35920191910e216A phase I/II, open-label, prospective, multicenter study to evaluate the efficacy and safety of lower doses of bortezomib plus busulfan and melphalan as a conditioning regimen in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation: The KMM103 studyChang Ki Min, Sung-Soo Park,
Current Oncology Reports10.1007/s11912-010-0125-02010126374-382Should Eligible Patients with T-Cell Lymphoma Receive High-Dose Therapy and Autologous Stem Cell Transplant in the Upfront Setting?Carla Casulo, Steven Horwitz,,
Annals of Oncology10.1093/annonc/mdu339.19201425iv332Clinical Outcome of Upfront High Dose Chemotherapy Plus Total Body Irradiation with Autologous Hematopoietic Stem Cell Transplantation in Patients Associated with T-Cell LymphomaC.H. Maeng, S.J. Kim, E. Um, H.A. Jung,,
Transfusion Medicine Reviews10.1016/s0887-7963(98)80104-1199812177Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients,
Value in Health10.1016/j.jval.2015.09.12122015187A464The Comparative Pharmacoeconomic Analysis Of Using Plerixafor For Stem Cell Mobilization For Autologous Peripheral Stem Cell Transplantation For Non-Hodgkin’s Lymphoma PatientsV Krysanova, I Krysanov,
British Journal of Haematology10.1046/j.1365-2141.2000.01841.x20001082415-423Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma Nolte, Buhmann, Emmerich, Schendel, Hallek,,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2011.12.2342012182S295Upfront Tandem Autologous Stem Cell Transplant Is Superior Than Autologous or Allogeneic Stem Cell Transplant After Failure of 1st Autologous Transplant in Patients with Multiple MyelomaC. Bachier, A. Wong, P. Shaughnessy, C.F. LeMaistre,
Annals of Oncology10.1093/annonc/5.suppl_2.s15119945S151-S153Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry dataG. Liberti, R. Pearce, G. Taghipour, I. Majolino, A.H. Goldstone,,